Do 25-hydroxyvitamin d levels correlate with fracture complications?

Abstract

Objectives: To determine the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and the likelihood of postoperative complications and fracture reoperation rate in orthopaedic trauma patients receiving vitamin D and calcium supplementation. Design: Retrospective case series. Setting: Level I trauma center, Midwestern United States. Patients: All orthopaedic trauma patients - 18 years or older - over a 20-month period were included with available initial and repeat 25(OH)D serum levels. In total, 201 patients met inclusion criteria. Intervention: All patients received 1000 IU of vitamin D3 and 1500 mg of calcium daily. Vitamin D deficient and insufficient patients also received 50,000 IU of ergocalciferol (vitamin D2) weekly until 25(OH)D levels normalized or fractures healed. Main Outcome Measurements: fracture complications and 25(OH)D levels. Results: Fifteen patients experienced postoperative healing complications. There was no significant difference between initial (P 0.92) or repeat (P 0.91) 25(OH)D levels between patients with and without fracture healing complications. Twenty-eight patients required repeat orthopaedic surgery. There was no significant difference between initial (P 0.62) or repeat (P 0.18) 25(OH)D levels between patients who did or did not require repeat orthopaedic surgery. There was no significant difference between initial (P 0.66) or repeat (P 0.89) 25(OH)D levels between patients who did or did not require nonorthopaedic surgery. Conclusions: Serum 25(OH)D levels did not significantly affect the likelihood of fracture healing complications requiring surgery or any nonorthopaedic injury-related surgery. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.